Source: International Congress 2018 – Experimental research in pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Esquivel-Ruiz (Madrid, Spain), B. Barreira (Madrid, Spain), M. Alvárez-Fuente (Madrid, Spain), A. Gurjian (Madrid, Spain), P. Hernández-Hernández (Madrid, Spain), Á. González-Murillo (Madrid, Spain), M. Ramírez-Orellana (Madrid, Spain), M. Del Cerro (Madrid, Spain), Á. Cogolludo (Madrid, Spain), F. Pérez-Vizcaíno (Madrid, Spain), L. Moreno (Madrid, Spain). Extracellular vesicles derived from mesenchymal stem cells prevent pulmonary vascular dysfunction induced by lipopolysaccharide (LPS).. 3056

Member's Comments

No comment yet.

Related content which might interest you: Adrenaline stimulated mesenchymal stem cells modulate inflammation in lipopolysaccharide induced lung injury Source: Annual Congress 2012 - Stem cells and progenitors in injury and repair Year: 2012 Secreted mediators from induced pluripotent stem cells (iPSc) attenuate fibrosis in bleomycin injured rat lung Source: Annual Congress 2012 - Stem cells and progenitors in injury and repair Year: 2012 Lipopolysaccharide (LPS) treatment enhances the regenerative capacity of mesenchymal stromal cells-derived exosomes Source: Virtual Congress 2021 – Molecular pathology and cell biology of pulmonary diseases Year: 2021 Inflammatory response and epithelial-mesenchymal transition based on the model of co-cultured alveolar epithelial cells and monocytes induced by lipopolysaccharide. Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases Year: 2017 Primary bronchial epithelial cells from stable lung allografts induce the differentiation of monocytes into macrophage like cells Source: Annual Congress 2008 - New insights and treatment options for bronchiolitis obliterans syndrome after lung transplantation Year: 2008 Protective effect of mesenchymal stem cells (MSC) on hypoxia-induced epithelial-mesenchymal transition of alveolar epithelial cells (AEC) Source: Annual Congress 2012 - Lung injury and repair: reactive oxygen species and beyond Year: 2012 Mitochondria related hormone stanniocalcin-1 (STC-1) derived from human multipotent stromal cells (MSCs) reduce cell death of human lung epithelial cell line (A549) under fetal acidosis and/or hypoxia Source: Annual Congress 2008 - Regulatory mechanisms of cell activation, renewal and recruitment Year: 2008 LSC - 2021 - Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension Year: 2021 Protective roles of paracrine factors of bone marrow mesenchymal stem cells in bleomycin induced lung epithelial cell injury in vitro and pulmonary fibrosis in vivo Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis Year: 2010 IL-11 promotes pulmonary vascular remodeling and lung fibrosis through the activation of endothelial to mesenchymal transition. Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis Year: 2020 Mesenchymal stromal cells (MSC) anti-microbial effect in acute respiratory distress syndrome (ARDS) is mediated in part by enhanced alveolar macrophage phagocytosis through cell contact-dependent mitochondrial transfer leading to improved macrophage bioenergetics Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair Year: 2016 Treprostinil indirectly regulates endothelial colony forming cell angiogenic properties by increasing VEGF-A produced by mesenchymal stem cells Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 Mast cells and macrophages affect homeostasis of pulmonary endothelial cells in a spheroidal cell culture model Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010 Epithelial fibroblast triggering and interactions in pulmonary fibrosis Source: Eur Respir Rev 2008; 17: 123-129 Year: 2008 The enhancement of Stanniocalcin-1 (STC1) secretion increases the ability of mesenchymal stem cells (MSCs) to reduce bleomycin-induced lung fibrosis in a mouse model through inhibition of endoplasmic reticulum stress (ER-stress)/TGFbeta1 pathway Source: International Congress 2014 – ILDs 1 Year: 2014 PP206 – Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids Source: ERS Lung Science Conference 2021 Year: 2021 Hyperoxia reversibly inhibits the transdifferentiation of alveolar type II (ATII) cells to alveolar type I (ATI) cells Source: Annual Congress 2005 - Cellular and molecular approaches to lung injury research Year: 2005 Human mesenchymal stem cell exosomes attenuate inflammation of lung epithelial cells through miR-223 in acute lung injury Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Therapeutic benefits of exosomes derived from mesenchymal stromal cells in bleomycin-induced pulmonary fibrosis in aged mice. Source: International Congress 2017 – Lung fibrosis: basic science Year: 2017 Distinct patterns of circulating endothelial cells in pulmonary hypertension Source: Eur Respir J 2010; 36: 1284-1293 Year: 2010